| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +270 K | 100% | $13.39 | +$3.62 M |
| Sells | 0 | ||||
| Net | +2 | +270 K | 100% | +$3.62 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Snehal Patel | CEO and CFO, Director, 10%+ Owner | $79 M | +$3.61 M | +4.78% | Jun 13, 2024 |
| David McWilliams | Director | $6.31 M | Jun 22, 2022 | ||
| Kenneth Hallock | Director | $4.04 M | Jun 22, 2022 | ||
| Jaye Thompson | VP Clinical Reg Affairs | $2.65 M | +$11.9 K | +0.45% | Oct 27, 2023 |
| Frank Daugherty | Chief Medical Officer, Director | $916 K | Jun 22, 2022 | ||
| Eric Rothe | Director | Jun 22, 2022 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|